Canada markets closed

Deciphera Pharmaceuticals, Inc. (DCPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.26+0.11 (+0.84%)
At close: 04:00PM EDT
13.26 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 883.99M
Enterprise Value 657.60M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.77
Price/Book (mrq)3.26
Enterprise Value/Revenue 6.56
Enterprise Value/EBITDA -2.33

Trading Information

Stock Price History

Beta (5Y Monthly) 1.40
52-Week Change 3-62.46%
S&P500 52-Week Change 3-11.93%
52 Week High 337.99
52 Week Low 36.51
50-Day Moving Average 311.30
200-Day Moving Average 313.96

Share Statistics

Avg Vol (3 month) 31.26M
Avg Vol (10 day) 31.48M
Shares Outstanding 566.22M
Implied Shares Outstanding 6N/A
Float 837.31M
% Held by Insiders 127.89%
% Held by Institutions 169.24%
Shares Short (Jun 14, 2022) 47.23M
Short Ratio (Jun 14, 2022) 47.47
Short % of Float (Jun 14, 2022) 416.90%
Short % of Shares Outstanding (Jun 14, 2022) 410.92%
Shares Short (prior month May 12, 2022) 47.55M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin -284.95%
Operating Margin (ttm)-258.72%

Management Effectiveness

Return on Assets (ttm)-33.05%
Return on Equity (ttm)-73.73%

Income Statement

Revenue (ttm)100.22M
Revenue Per Share (ttm)1.72
Quarterly Revenue Growth (yoy)16.20%
Gross Profit (ttm)-141.62M
EBITDA -256.21M
Net Income Avi to Common (ttm)-285.56M
Diluted EPS (ttm)-4.90
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)256.55M
Total Cash Per Share (mrq)3.87
Total Debt (mrq)30.16M
Total Debt/Equity (mrq)11.11
Current Ratio (mrq)3.69
Book Value Per Share (mrq)4.63

Cash Flow Statement

Operating Cash Flow (ttm)-224.49M
Levered Free Cash Flow (ttm)-111.47M